Trials / Unknown
UnknownNCT03865966
Hepatitis B Virus Infection After Liver Transplantation in Children
Clinical Follow-up Study on Hepatitis B Virus Infection After Liver Transplantation in Children
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- Qiu Li · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
China is a highly prevalent area of hepatitis B virus（HBV） infection, with at least 75 million hepatitis B virus carriers, and 80% of primary hepatocellular carcinoma (HCC) is associated with chronic hepatitis B virus infection. Liver transplantation is currently the preferred method for end-stage liver disease such as biliary atresia and cirrhosis in children. In recent years, children's liver transplantation has developed rapidly and the number of developments has increased significantly. If there is chronic hepatitis B virus infection in the donor liver, it may cause HBV transmission, or the patient may have a low-load occult hepatitis B virus infection, and after immunosuppressive treatment, it may lead to hepatitis B virus infection after surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | — | No intervention |
Timeline
- Start date
- 2019-07-05
- Primary completion
- 2023-12-31
- Completion
- 2025-12-31
- First posted
- 2019-03-07
- Last updated
- 2019-07-08
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03865966. Inclusion in this directory is not an endorsement.